ctrl K

TriSalus Life Sciences In... (TLSI)

NASDAQ: TLSI · Real-Time Price · USD

5.01

-0.08 (-1.57%)

At close: May 02, 2025, 12:58 PM

TriSalus Life Sciences Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	8.53M	11.78M	9.41M	30.3M	1.33M
Short-Term Investments	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	350K	19.83M	250.01M	250M
Other Long-Term Assets	61.73M	116K	367K	115K	50K
Receivables	n/a	3.55M	1.56M	1.36M	617K
Inventory	4.05M	2.54M	1.47M	1.29M	567K
Other Current Assets	n/a	n/a	n/a	n/a	2.89M
Total Current Assets	20.67M	20.86M	17.21M	35.13M	2.01M
Property-Plant & Equipment	2.66M	3.27M	3.61M	1.8M	1.26M
Goodwill & Intangibles	n/a	1.13M	802K	794K	736K
Total Long-Term Assets	64.4M	4.86M	4.78M	2.71M	250M
Total Assets	23.97M	25.73M	22M	37.84M	252.01M
Account Payables	2.27M	3.39M	4.95M	1.3M	612K
Deferred Revenue	n/a	n/a	6.38M	n/a	-42.8M
Short-Term Debt	n/a	n/a	n/a	n/a	42.18M
Other Current Liabilities	2.84M	4.45M	23.57M	1.94M	103.22K
Total Current Liabilities	10.23M	14.69M	32.36M	6.37M	103.22K
Long-Term Debt	22.08M	n/a	n/a	544K	n/a
Other Long-Term Liabilities	16.22M	35.73M	164.38M	160.52M	23.39M
Total Long-Term Liabilities	39.64M	36.98M	165.97M	161.07M	23.39M
Total Liabilities	49.87M	51.66M	198.32M	167.44M	23.5M
Total Debt	23.63M	1.59M	1.96M	544K	42.18M
Common Stock	n/a	2K	14K	11K	890.00
Retained Earnings	-279.55M	-248.38M	-186.36M	-136.34M	-711.39K
Comprehensive Income	n/a	n/a	-164.01M	-160.51M	-890
Shareholders Equity	-25.89M	-25.94M	-176.33M	-129.6M	228.52M
Total Investments	n/a	350K	19.83M	250.01M	250M